A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC

The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.

Investigators